The BridgeTech Program is a year-long national professional development program that helps researchers and entrepreneurs learn how to successfully navigate the medtech commercialisation pathway and bring products to market.

Convened and administered by QUT, the program is led by a collaborative consortium of medtech companies, universities, and industry associations. The program gives participants the skills and networks they need to succeed in the medtech industry through online training, webinars, a speaker series, and a 3-day Symposium to meet the cohort and partners. Up to 80 people are selected to participate each year, which is accessible from anywhere in Australia.

 

We’re excited to invite new participants from across Australia to join our 2026 cohort. We’re looking for up to 80 brilliant new entrepreneurs, medtech innovators, start ups and clinicians. Start your commercialisation journey off strong in the new year and apply now! Visit our application page for more information including course outline, fees and eligibility requirements.

 

 

Launched in 2018, the BridgeTech Program was awarded industry-matched funding through both MTPConnect’s Project Fund Program and the Medical Research Future Fund’s Biomedical Translation Bridge Program (BTB), and the Clinical Translation and Commercialisation Medtech (CTCM) Program until 2025. To learn more, visit the MTPConnect website.